car t-cell therapy - Unilever Edu

ASCO 2023 revealed breakthroughs in cancer treatment, from genomic testing and CAR T-cell therapy management.....Read more

06
Dec

$Enhancing CD5 CAR T-Cell Therapy with TKIs for Relapsed/Refractory T-ALL$

CD5 CAR T-cell therapy combined with TKIs offers a novel approach for relapsed/refractory T-ALL. This.....Read more

05
Dec

Axicabtagene ciloleucel (Yescarta) significantly improves survival in large B-cell lymphoma compared to standard treatment. This.....Read more

05
Dec

$Inotuzumab Ozogamicin: A Breakthrough for Pediatric Relapsed/Refractory B-Cell ALL$

Inotuzumab ozogamicin offers new hope for children with relapsed/refractory B-cell ALL. This targeted therapy has.....Read more

29
Nov

Almost a decade ago, the FDA approved daratumumab (Darzalex), a groundbreaking monoclonal antibody for multiple.....Read more

26
Nov